ImmunoCellular Therapeutics (IMUC) Reports Q4 Loss of $1.23/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results
March 13, 2018 4:05 PM EDTLOS ANGELES, March 13, 2018 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE American: IMUC) today announced financial results for the fourth quarter and full year ended December 31, 2017. Â
Anthony J. Gringeri, PhD, President and... More
